(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride

INTERMEDIATES


We Guarantee Best Price for this compound*
If you get a better price we will match the same.
 
Product Details

CAT No.# CS-O-10731
Category Intermediates
CAS 709031-39-0
Molecular Weight 162.61
Molecular Formula C6H11ClN2O
Stock Status: In-Stock
Purity: >98%
Synonyms: (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride
Application Notes: Intermediate of Saxagliptin
Shipping: Free Shipping for worldwide on order above 2000 USD
COA:    View COA
(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Worldwide Suppliers of (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Intermediates Clearsynth CS-O-10731

Product rating: 9 (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride based on 20 ratings

  1. Intermediates
  2. (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride

PEOPLE ALSO SEARCHED FOR: 1. propan-2-yl-5-hydroxy-2-methyl-2-4-(3-nitrophenyl)-6-oxo-1,4,5,5-tetraahydropyridine-3-carboxylate
2. ([13C6]Leu5)-Ghrelin (human) (H-7252.1000)
3. Lauroside D
4. Triazolam 13C D3
5. Icatibant impurity 1
6. BISPHENOL AF (RING-13C12)
7. 0.1% TFA in Water ULC-MS
8. Metamizole EP Impurity C HCl
9. Silodosin Metabolite D4
10. Silodosin Metabolite
11. 2-Phenoxymethanesulfonanilide
12. Nimesulide EP Impurity A
13. Acetone HPLC
14. Nandrolone Decanoate EP impurity F
15. N-(4-Bromophenyl)-3-methyl-N-(m-tolyl)aniline
16. Ortho toluene sulfonic acid
17. Sucrose (1623637)
18. Crisaborole m-Isomer
19. Riluzole (1604337)
20. Pheniramine impurity B


Smileys:
NC([C@@H]1C[C@H](C2)[C@H]2N1)=O.Cl



This page contains information about (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Cas 709031-39-0 and its Intermediates.

(1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Worldwide Suppliers of (1S,3S,5S)-2-Azabicyclo[3.1.0]hexane-3-carboxamide hydrochloride Intermediates Clearsynth 709031-39-0

"Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271(e)+A13(1). Any patent infringement and resulting liability is solely at buyer risk."